- Home
- LPG vs PGEN Comparison
LPG vs PGEN Comparison
Compare LPG & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | PGEN |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LPG | PGEN |
|---|---|---|
| Price | $30.12 | $3.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $35.00 | $7.67 |
| AVG Volume (30 Days) | 541.9K | ★ 4.3M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $353,341,476.00 | $230,981,000.00 |
| Revenue This Year | $33.36 | $342.78 |
| Revenue Next Year | N/A | $478.46 |
| P/E Ratio | $11.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.66 | $1.11 |
| 52 Week High | $38.40 | $5.47 |
Technical Indicators
Market Signals| Indicator | LPG | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 37.47 | 34.44 |
| Support Level | $30.04 | $2.99 |
| Resistance Level | $32.24 | $5.10 |
| Average True Range (ATR) | 1.30 | 0.22 |
| MACD | -0.87 | -0.05 |
| Stochastic Oscillator | 1.13 | 5.83 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.